Sequencing Driven Metagenomics
Sequencing Driven Metagenomics

Sequencing Driven Metagenomics Market Forecast by 2019-2026 | Danaher, Merck KGaA, Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN, F. Hoffmann-La Roche Ltd,Novogene Corporation, PerkinElmer Inc.,Arc Bio, LLC

The research report published by Data Bridge Market research report provides the all-inclusive data regarding the market with growth, share, size and recent market trends. Upcoming advancement in the market

In this report, Researchers have analyzed Strength, Weakness, opportunities and threats in the market and provides the unbiased picture of the market with the Qualitative and informative knowledge. The Global Sequencing Driven Metagenomics Market report additionally states import/trade utilization, free market activity figures, cost, value, volume and gross edges.

Get FREE Sample Report at https://databridgemarketresearch.com/request-a-sample/?dbmr=global-sequencing-driven-metagenomics-market

Global Sequencing Driven Metagenomics Market By Product (Kits & Reagents, Sequencing & Data Analytics Services, Instruments, Consumables, Others), Application (Environmental, Human Health, Agriculture, Biotechnology, Biofuel, Others), End-Users (Pharmaceutical Industries, Biotechnology Companies, Research Laboratories, Pathology Laboratories, Academic & Research Institutes, Others), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2026

Global sequencing driven metagenomics market is expected to register a steady CAGR in the forecast period of 2019-2026. The report contains data from the base year of 2018 and the historic year of 2017. This rise in market value can be attributed to the increasing investments undertaken by various organizations along with the increasing application areas of metagenomics in industries, life-sciences and biotechnological areas.

Global sequencing driven metagenomics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of sequencing driven metagenomics market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa. Few of the major competitors currently working in the global sequencing driven metagenomics market are

Danaher; Merck KGaA; Illumina, Inc.; Thermo Fisher Scientific Inc.; QIAGEN; F. Hoffmann-La Roche Ltd; Novogene Corporation; PerkinElmer Inc.; Arc Bio, LLC; Bio-Rad Laboratories, Inc.; Agilent Technologies, Inc.; Promega Corporation; Takara Bio Inc.; IntegraGen; Zymergen; Pacific Biosciences of California, Inc.; BGI; Eurofins Scientific; Macrogen Inc.; yaazhxenomics.com; CD Genomics; Microsynth AG; GENEWIZ; SciGenom Labs Pvt. Ltd; BaseClear B.V.; Swift Biosciences Inc.; ENTEROME; Aperiomics, Inc.; Second Genome and Cosmosid Inc among others.

Market Drivers

  • Trend of decreased costs associated individual sequencing analysis is expected to drive the growth of the market
  • Increasing understanding and advancements in the technologies of DNA sequencing methods is also expected to drive the growth of the market
  • Availability of better understanding the functions, characteristics and strains of microbes in the environment through this technique are factors driving the growth of the market

Market Restraints

  • Lack in the availability of standards and inaccurate nature of this technique for diagnostic testing is also expected to restrict the adoption rate
  • Absence of knowledgeable professionals in the market is also expected to restrain the growth of the market

Key Developments in the Market:

  • In April 2019, Pacific Biosciences of California Inc. announced that they had initiated the commercialization of “Sequel II System”, inclusive of “SMRT Cell 8M”, instrument control software, chemistry and “SMRT Link” software package. This combined system will help in significant reduction of costs and time required as compared to the previous “Sequel System” available in the market
  • In November 2018, Illumina, Inc. announced that they had agreed to acquire Pacific Biosciences of California, Inc. This acquisition will help extend the capabilities of sequencing genomic solutions available with the company. This acquisition will extend Illumina’s short-read sequencing platforms by including the long-term sequencing platforms of Pacific Biosciences

Get FREE TOC at  https://databridgemarketresearch.com/toc/?dbmr=global-sequencing-driven-metagenomics-market

Segmentation: 

By Product

  • Kits & Reagents
    • Library Preparation Kits
    • Sample Extraction Kits
    • Metagenomic Sequencing Kits
  • Sequencing & Data Analytics Services
  • Instruments
  • Consumables
  • Others

By Application

  • Environmental
  • Human Health
    • Infectious Disease Diagnostics
    • Gut Microbe Characterization
  • Agriculture
  • Biotechnology
    • Biosurfactants & Antibiotics Production
    • Clinical Diagnostics
    • Microbial Diversity
  • Biofuel
  • Others

By End-Users

  • Pharmaceutical Industries
  • Biotechnology Companies
  • Research Laboratories
  • Pathology Laboratories
  • Academic & Research Institutes
  • Others
    • Environmental Institutes
    • Chemical Companies
    • Others

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East and Africa

Reasons to Purchase this Report

  • Current and future of global sequencing driven metagenomics market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

Buy Full Report Now at https://databridgemarketresearch.com/checkout/buy/enterprise/global-sequencing-driven-metagenomics-market

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: Corporatesales@databridgemarketresearch.com

About Data Bridge Market Research 12411 Articles
Hi, I am Ravi Kumar, a Blogger, Freelancer, SEO Consultant, an Internet Marketer, I am a research analyst who loves to evaluate data relating to Manufacturing industry, Management of companies and enterprises, Finance and insurance, Wholesale trade, Management, scientific, and technical consulting services

Leave a Reply

Your email address will not be published.


*